-
Enhancing Antimicrobial Susceptibility Testing: Insights from Prof. Gunnar Kahlmeter at ECCMID 2023
The 33rd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), held in Copenhagen, Denmark from April 15th to 18th, 2023, provided a valuable platform for the exchange of knowledge…
-
Current Challenges in Treating Gram-Positive Bacterial Infections: Insights from ECCMID 2023 Interview with Dr. José Luis Del Pozo
The field of infectious diseases constantly evolves, presenting clinicians and researchers with new challenges. At the 33rd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2023), held in Copenhagen,…
-
CAR-T: A Promising Breakthrough in Fungal Infection Treatment—Insights from ECCMID 2023
The 33rd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) held in Copenhagen, Denmark, from April 15th to 18th, 2023, brought together experts in the field to discuss the…
-
Interview with Chao Zhuo at ECCMID 2023
The 33rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) took place in Copenhagen, Denmark, from April 15th to 18th, 2023. As one of the most significant conferences in the field of clinical microbiology and infectious diseases, it marked a significant gathering after a three-year hiatus due to the pandemic. Chinese experts, including Dr.…
-
Dr. Heather-Marie Schmidt: WHO Long-Acting PrEP Guidelines and Priority Actions to End HIV Epidemic in Asia
Heather-Marie Schmidt BMedSc (Hon), MPH, PhD Dr. Schmidt serves as the Regional Advisor on HIV Testing, Prevention, and Key Populations for the Joint United Nations Programme on HIV/AIDS (UNAIDS) Asia-Pacific Regional Office and the World Health Organization (WHO) Global HIV, Hepatitis, and Sexually Transmitted Infections Program. She is dedicated to developing global guidelines for PrEP…
-
Dr. Hongzhou Lu: Focus on the Aging of HIV/AIDS Patients, Intrinsic Capacity Assessment is Imperative!
In recent years, with the effectiveness of antiretroviral therapy (ART) in suppressing HIV replication, the life expectancy of HIV-infected individuals has significantly increased. At the same time, the trend of aging among HIV/AIDS patients has gradually become a research hotspot in the field. From June 8th to 10th, 2023, the Asia Pacific AIDS and Co-infections…
-
Dr. Iskandar Azwa: Second and Third-Line Treatment Options for HIV/AIDS Patients
Dr. Iskandar Azwa Chairman of the Malaysian AIDS Council, Head of Infectious Diseases Department at the University of Malaya Medical Center. His research interests include pre-exposure prophylaxis (PrEP) implementation in key populations, HIV drug resistance, and evaluating new HIV treatment strategies. He is the principal investigator for several international collaborative HIV clinical trials, including TAHOD,…
-
Dr. Jennifer Hoy: How to Safely Transition ART in HIV Patients Achieving Viral Suppression?
Infectious Disease/HIV Specialist and Medical Professor at Monash University Alfred Hospital, Australia. Member of the Australian Antiretroviral Guidelines Committee and the International Antiviral Society-USA (IAS-USA) Antiretroviral Guidelines Panel. Leading and participating in the development of new antiretroviral drugs and the prevention and management of opportunistic infections, with a primary research focus on complications related to…
Connecting Medical Expertise through Media